Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: New Zealand Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20081
20091
20111
20123
20133
20151
20171
20181
20193
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Bristol-Myers Squibb2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
National Medical Research Council (NMRC), Singapore2
ABK Biomedical1
Daiichi Sankyo1
Eli Lilly and Company1
Exelixis1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular20
Liver Neoplasms7
Neoplasms2
Bronchiolitis Obliterans Syndrome1
Carcinoma1
Colorectal Neoplasms1
Hepatitis1
Hepatitis C1
Liver Diseases1
Vaccinia1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.